The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
about
Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trialsBipolar disorder: new perspectives in health care and preventionMobile Apps for Bipolar Disorder: A Systematic Review of Features and Content QualityBridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practiceWhen to start aripiprazole therapy in patients with bipolar maniaQuetiapine monotherapy in bipolar II depression: combined data from four large, randomized studiesThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmThe International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelinesA review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSPThe International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disordersGuidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland China.Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns.Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China.Quetiapine for acute bipolar depression: a systematic review and meta-analysisAntidepressant treatment for acute bipolar depression: an update.Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.An item response theory evaluation of three depression assessment instruments in a clinical samplePharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDYThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional studyKorean Medication Algorithm Project for Bipolar Disorder: third revision.Who will benefit from antidepressants in the acute treatment of bipolar depression? A reanalysis of the STEP-BD study by Sachs et al. 2007, using Q-learningBroadening the diagnosis of bipolar disorder: benefits vs. risks.Management of bipolar depressionWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response.Mood regulation in bipolar disorders viewed through the pendulum dynamics concept.Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines.A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar DisorderSelective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII.ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depressionDifferences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil.Update on extended release quetiapine fumarate in schizophrenia and bipolar disordersA critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder.Evidence review and clinical guidance for the use of ziprasidone in Canada.
P2860
Q21260328-35DBBC18-238A-421B-8747-B5752AF86CEBQ24606335-27689819-E496-43B4-AC41-0A8EE91C2053Q26797449-823C8AFB-EE34-4405-9DDF-2EAC411B3E79Q26800235-633778D0-1FBA-42BB-AB54-73344A306251Q27014860-F8939088-8A1D-48A4-8167-01F33B23199CQ27499305-6C7D24DA-C34D-492F-8A80-8F3AA27FEB18Q28066714-01A845BC-54FF-4B78-B570-F33D3DAE6681Q28069743-CB04C114-C3F3-4ED3-96E5-75240375315BQ30353864-9AB7DF99-95EC-49AC-8394-10130BBEFC53Q30569917-07BE033B-D314-4CE4-94B6-2123EA17C7BAQ30583384-E08FDBB7-7E81-4CCB-8661-2A77BAB4AA73Q30808402-0EC9C702-F30B-45BB-984F-1157CEE6A267Q33606886-B8C80979-C8DE-4AF1-A044-0C011A71BEF5Q33770623-F2CCFC00-3D3D-48A3-940E-889039E02F6FQ33829611-5A341F86-AEDE-4589-9F85-B1D295D5C736Q34154885-FCA771CA-22B7-4816-B680-8FA54ECE6298Q34197988-22737295-04FE-4899-8627-7B8B96BAA77CQ34312864-90B3F64A-1C05-49A8-8ED1-DE9920A158A6Q34349641-D7F0851F-16A0-40D9-B74F-9916C515CF41Q34389967-90D24321-1836-4AFE-9904-F0948A6848BBQ34459114-4878AB6E-C236-44B3-A44A-3F10B1757B78Q34515834-55D44DB8-400C-429F-AF07-41B66456C9A3Q34649187-0A11AE65-EBE3-4157-B2D5-466E31C87359Q34654574-18F02022-3A4B-4044-A843-999711DA2784Q34833550-5C50F4D8-25C4-4F78-97B8-20CF0872F270Q35142737-D281A559-C3A0-4BA8-BDA1-61E7929BDABBQ35252303-EF3B2484-CE96-4CED-902C-63D78E98EF63Q35285927-1C57D61E-146C-497D-A952-EDE9CF3E5901Q35365539-F283B8F3-9022-49D4-8ABA-129B016DAE57Q35560309-0C8EB11F-32E5-4B34-AD6C-E3E71047E568Q35661570-E39E75C9-17E1-4FE1-905E-1571ACC9B8FCQ35675370-B65A7ACE-C622-4B16-BA6C-E26EAB02E2EDQ35822006-A0F9CE74-2C1D-4891-9D4F-4FFE11B4F73CQ35965634-4A6A4A73-4E56-43D7-AAD2-F1B1E80DBD3EQ35982233-91595F08-2010-4555-87AD-8DAE630F195AQ36374843-28B840D6-6B53-4D9C-AC9F-30AC73219A59Q36377434-E2862563-0877-4DC5-9A0C-36ED510E7B68Q36393992-397CE625-C1B2-4141-B333-A91B6927D998Q36560064-C5CD718E-9019-4C24-9674-E46BAD0A476AQ36588607-763CFB6F-040C-43CF-B7D9-1D4251945C3C
P2860
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The World Federation of Societ ...... t of acute bipolar depression.
@ast
The World Federation of Societ ...... t of acute bipolar depression.
@en
type
label
The World Federation of Societ ...... t of acute bipolar depression.
@ast
The World Federation of Societ ...... t of acute bipolar depression.
@en
prefLabel
The World Federation of Societ ...... t of acute bipolar depression.
@ast
The World Federation of Societ ...... t of acute bipolar depression.
@en
P2093
P2860
P50
P1476
The World Federation of Societ ...... t of acute bipolar depression.
@en
P2093
Charles Bowden
Guy M Goodwin
Rasmus W Licht
WFSBP Task Force On Treatment Guidelines For Bipolar Disorders
P2860
P304
P356
10.3109/15622970903555881
P577
2010-03-01T00:00:00Z